| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO | /s/ James R. Oehler, Attorney-in-Fact | 17 Feb 2026 | 0001910662 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HALO | Common Stock | Options Exercise | $0 | +5,093 | +23% | $0.000000 | 27,172 | 16 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $218,222 | -2,747 | -10% | $79.44 | 24,425 | 16 Feb 2026 | Direct | F1 |
| transaction | HALO | Common Stock | Options Exercise | $0 | +5,329 | +22% | $0.000000 | 29,754 | 16 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $228,311 | -2,874 | -9.7% | $79.44 | 26,880 | 16 Feb 2026 | Direct | F2 |
| transaction | HALO | Common Stock | Options Exercise | $0 | +13,351 | +50% | $0.000000 | 40,231 | 16 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $577,767 | -7,273 | -18% | $79.44 | 32,958 | 16 Feb 2026 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HALO | Restricted Stock Units | Options Exercise | $0 | -5,093 | -100% | $0.000000 | 0 | 16 Feb 2026 | Common Stock | 5,093 | $0.000000 | Direct | F4 |
| transaction | HALO | Restricted Stock Units | Options Exercise | $0 | -5,329 | -50% | $0.000000 | 5,329 | 16 Feb 2026 | Common Stock | 5,329 | $0.000000 | Direct | F4 |
| transaction | HALO | Performance Stock Units | Options Exercise | $0 | -13,351 | -100% | $0.000000 | 0 | 16 Feb 2026 | Common Stock | 13,351 | $0.000000 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The reported disposition of 2,747 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F2 | The reported disposition of 2,874 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F3 | The reported disposition of 7,273 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F4 | This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| F5 | This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |